PharmaShots
APRIL 25, 2023
This drug is currently in multiple P-IIa clinical trials and is being evaluated in combination with other antiviral agents for cHBV. Founded Year: 2018 Total Employees: ~80 Headquarters: California, United States Market Cap: $43.1M It is a subcutaneous RNAi therapeutic designed to reduce HBV viral antigens, including HBsAg.
RX Note
FEBRUARY 23, 2023
Soft Contact Lenses - A basic overview Red Eye - Discussion on few possible conditions Styes - Warm compresses are the mainstay of treatment Eye Floaters - It is not often treated, except in severe cases.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Thyroid Pharmacist
JULY 20, 2023
5] A 2018 study found that in women with persistent symptoms of hypothyroidism despite levothyroxine therapy, two-thirds were able to eliminate their symptoms when they got their ferritin levels over 100 µg/l. [6] And as we’ve seen, even with supplementation, you need to address your root causes to prevent iron supply and demand challenges.
The Thyroid Pharmacist
JANUARY 20, 2023
Nikolai Lazarev defined adaptogens as “an agent that raises the body’s ability to resist stress by countering undesired stressors, whether physical, chemical, emotional, or biological.” Would you like to know if adaptogenic herbs might be of benefit to you? This can also mean fewer nutrients are absorbed.
Putting Patients First Blog
NOVEMBER 12, 2024
Recognizing PrEP as a preventive service rather than as indicative of an active medical condition, as HHS proposes, could help address the current risk selection seen in the market. Clear guidance on the treatment of rebates within the ACF will help avoid distortions in pricing and prevent patients from bearing disproportionate costs.
Expert insights. Personalized for you.
40 
Let's personalize your content